Description
A CYP17 inhibitor (IC50 = 300 nM) that competitively blocks synthetic androgen binding (EC50 = 845 nM) and antagonizes the androgen receptor in transcriptional activation assays; inhibits the growth of castration-resistant prostate cancer cells (IC50 = 2.9 µM)